Abstract
BackgroundPancreatic ductal adenocarcinoma (PDAC) represents a major clinical challenge due to its tumor microenvironment, which exhibits immune-suppressive properties that facilitate cancer progression, metastasis, and therapy resistance. Interleukin 1 (IL-1) signaling...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have